A naukri.com initiative
Bioengineer
1w
285
Image Credit: Bioengineer
New Nomogram Predicts Liver Cancer Prognosis
- Researchers have developed a new nomogram that uses the biomarker Interleukin-41 to predict liver cancer prognosis post-surgery, as per a study in BMC Cancer.
- Hepatocellular carcinoma (HCC) poses challenges due to high recurrence rates even after successful surgery, leading to poor long-term survival.
- A study by Mu, Z. et al. analyzed 224 HCC patients who underwent R0 resection, focusing on molecular predictors of prognosis.
- High IL-41 expression correlated with increased recurrence and mortality risks in patients, emphasizing its prognostic relevance.
- Vascular features such as intratumoral artery presence and microvascular invasion were linked to higher recurrence risk.
- Tumor size, liver enzyme levels like AST, and IL-41 were integrated into nomograms for personalized risk prediction.
- The nomogram's accuracy in forecasting recurrence and mortality surpasses traditional staging systems, aiding in tailored patient management.
- IL-41's role in HCC prognosis sheds light on potential therapeutic targets and interventions for improved patient outcomes.
- The nomogram's comprehensive approach integrates molecular, pathological, and clinical data, enhancing prognostic precision in HCC.
- Further validation in diverse populations and exploration of interventions targeting IL-41 or vascular features is warranted for broader clinical impact.
Read Full Article
17 Likes
For uninterrupted reading, download the app